Zoltan Mari

Zitiert von

	Alle	Seit 2020
Zitate	11387	7004
h-index	44	37
i10-index	105	92

1500

750

375

1125

200720082009201020112012201320142015201620172018201920202021202220232024202538 37 76 86 126 178 220 297 404 526 576 739 886 1107 1392 1492 1407 1461 127

Öffentlicher Zugriff

Alle anzeigen

98 Artikel

8 Artikel

verfügbar

nicht verfügbar

Basierend auf Fördermandaten

Koautoren

Greg PontoneJohns Hopkins University School of MedicineBestätigte E-Mail-Adresse bei jhmi.edu
Liana RosenthalAssistant Professor of Neurology. Johns HopkinsBestätigte E-Mail-Adresse bei jhmi.edu
Kelly MillsJohns Hopkins UniversityBestätigte E-Mail-Adresse bei jhmi.edu
Alexander PantelyatAssociate Professor of Neurology, Johns Hopkins University School of MedicineBestätigte E-Mail-Adresse bei jhmi.edu
Ou BaiFlorida International UniversityBestätigte E-Mail-Adresse bei fiu.edu
Kate PerepezkoAssistant Scientist at the Scripps Gerontology CenterBestätigte E-Mail-Adresse bei miamioh.edu
Ted M. DawsonDirector, Institute for Cell Engineering, Professor of Neurology and Neuroscience, JHUSoMBestätigte E-Mail-Adresse bei jhmi.edu
Jared T HinkleJohns Hopkins School of MedicineBestätigte E-Mail-Adresse bei jhmi.edu
Ivan Bodis-WollnerSUNY Downstate Medical CenterBestätigte E-Mail-Adresse bei downstate.edu
Dr.Yousef SalimpourAssistant Professor of Neurology and Neurological Surgery, Johns Hopkins School of MedicineBestätigte E-Mail-Adresse bei jhu.edu
Jason BrandtProfessor Emeritus of Psychiatry & Behavioral Sciences, Johns Hopkins UniversityBestätigte E-Mail-Adresse bei jhmi.edu
Guido NolteDept. of Neurophysiology and Pathophysiology, UKE, HamburgBestätigte E-Mail-Adresse bei uke.de
Anto Bagic, MD, PhD, FAES, FACNSUniversity of PittsburghBestätigte E-Mail-Adresse bei upmc.edu
Ankur Butala MDJohns Hopkins University School of MedicineBestätigte E-Mail-Adresse bei jhmi.edu
Bastiaan R. BloemProfessor of movement disorders neurology, Radboudumc, Nijmegen, the NetherlandsBestätigte E-Mail-Adresse bei radboudumc.nl
Kelvin L. ChouProfessor of Neurology and NeurosurgeryBestätigte E-Mail-Adresse bei med.umich.edu
Hubert FernandezDirector, Center for Neurological Restoration, Cleveland ClinicBestätigte E-Mail-Adresse bei ccf.org
Arman RahmimProfessor of Radiology, Physics and Biomedical Engineering, University of British ColumbiaBestätigte E-Mail-Adresse bei ubc.ca
Susan BassettAssociate Professor of Psychiatry, Johns Hopkins UniversityBestätigte E-Mail-Adresse bei jhmi.edu
Mark HallettDistinguished NIH Investigator Emeritus, NINDS, NIHBestätigte E-Mail-Adresse bei ninds.nih.gov

Folgen

Zoltan Mari

Cleveland Clinic

Bestätigte E-Mail-Adresse bei ccf.org - Startseite

Parkinson's disease


Titel Nach Zitationen sortieren Nach Jahr sortieren Nach Titel sortieren	Zitiert von Zitiert von	Jahr
Identifying true brain interaction from EEG data using the imaginary part of coherency G Nolte, O Bai, L Wheaton, Z Mari, S Vorbach, M Hallett Clinical neurophysiology 115 (10), 2292-2307, 2004	1949	2004
The Parkinson progression marker initiative (PPMI) K Marek, D Jennings, S Lasch, A Siderowf, C Tanner, T Simuni, C Coffey, ... Progress in neurobiology 95 (4), 629-635, 2011	1703	2011
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease SP Yun, TI Kam, N Panicker, SM Kim, Y Oh, JS Park, SH Kwon, YJ Park, ... Nature medicine 24 (7), 931-938, 2018	995	2018
Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau₁₈₁, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson … JH Kang, DJ Irwin, AS Chen-Plotkin, A Siderowf, C Caspell, CS Coffey, ... JAMA neurology 70 (10), 2013	454	2013
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit MF Beal, D Oakes, I Shoulson, C Henchcliffe, WR Galpern, R Haas, ... JAMA neurology 71 (5), 543-552, 2014	314	2014
Tourette syndrome deep brain stimulation: a review and updated recommendations LE Schrock, JW Mink, DW Woods, M Porta, D Servello, ... Movement disorders 30 (4), 448-471, 2015	272	2015
Efficacy and safety of deep brain stimulation in Tourette syndrome: the international Tourette syndrome deep brain stimulation public database and registry D Martinez-Ramirez, J Jimenez-Shahed, JF Leckman, M Porta, D Servello, ... JAMA neurology 75 (3), 353-359, 2018	245	2018
National randomized controlled trial of virtual house calls for Parkinson disease CA Beck, DB Beran, KM Biglan, CM Boyd, ER Dorsey, PN Schmidt, ... Neurology 89 (11), 1152-1161, 2017	220	2017
Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought P Rabins, BS Appleby, J Brandt, MR DeLong, LB Dunn, L Gabriëls, ... Archives of general psychiatry 66 (9), 931-937, 2009	216	2009
Widespread abnormality of the γ-aminobutyric acid-ergic system in Tourette syndrome A Lerner, A Bagic, JM Simmons, Z Mari, O Bonne, B Xu, D Kazuba, ... Brain 135 (6), 1926-1936, 2012	202	2012
The past, present, and future of telemedicine for Parkinson's disease M Achey, JL Aldred, N Aljehani, BR Bloem, KM Biglan, P Chan, E Cubo, ... Movement disorders 29 (7), 871-883, 2014	199	2014
Asymmetric spatiotemporal patterns of event-related desynchronization preceding voluntary sequential finger movements: a high-resolution EEG study O Bai, Z Mari, S Vorbach, M Hallett Clinical neurophysiology 116 (5), 1213-1221, 2005	195	2005
Diffusion, spread, and migration of botulinum toxin J Ramirez‐Castaneda, J Jankovic, C Comella, K Dashtipour, ... Movement disorders 28 (13), 1775-1783, 2013	194	2013
Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial K Kieburtz, BC Tilley, JJ Elm, D Babcock, R Hauser, GW Ross, ... Jama 313 (6), 584-593, 2015	182	2015
Neuroimaging of neuronal circuits involved in tic generation in patients with Tourette syndrome A Lerner, A Bagic, EA Boudreau, T Hanakawa, F Pagan, Z Mari, ... Neurology 68 (23), 1979-1987, 2007	132	2007
Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls B Mollenhauer, CJ Caspell-Garcia, CS Coffey, P Taylor, LM Shaw, ... Neurology 89 (19), 1959-1969, 2017	131	2017
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial GU Höglinger, I Litvan, N Mendonca, D Wang, H Zheng, ... The Lancet Neurology 20 (3), 182-192, 2021	130	2021
Continuous assessment of levodopa response in Parkinson's disease using wearable motion sensors CL Pulliam, DA Heldman, EB Brokaw, TO Mera, ZK Mari, MA Burack IEEE Transactions on Biomedical Engineering 65 (1), 159-164, 2017	130	2017
Involvement of insula and cingulate cortices in control and suppression of natural urges A Lerner, A Bagic, T Hanakawa, EA Boudreau, F Pagan, Z Mari, ... Cerebral cortex 19 (1), 218-223, 2009	122	2009
Efficacy of nilotinib in patients with moderately advanced Parkinson disease: a randomized clinical trial T Simuni, B Fiske, K Merchant, CS Coffey, E Klingner, C Caspell-Garcia, ... JAMA neurology 78 (3), 312-320, 2021	119	2021

Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.

Artikel 1–20

Zitate pro Jahr

Doppelte Zitate

Zusammengeführte Zitate

Koautor hinzufügenKoautoren

Folgen

Zitiert von

Koautoren